0001209191-22-055325.txt : 20221102
0001209191-22-055325.hdr.sgml : 20221102
20221102164014
ACCESSION NUMBER: 0001209191-22-055325
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221101
FILED AS OF DATE: 20221102
DATE AS OF CHANGE: 20221102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harbin Stephen
CENTRAL INDEX KEY: 0001835251
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39575
FILM NUMBER: 221354747
MAIL ADDRESS:
STREET 1: C/O ONCORUS, INC.
STREET 2: 50 HAMPSHIRE STREET, SUITE 401
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncorus, Inc.
CENTRAL INDEX KEY: 0001671818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473779757
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4 CORPORATE DRIVE
CITY: ANDOVER
STATE: MA
ZIP: 01810
BUSINESS PHONE: 857-320-6400
MAIL ADDRESS:
STREET 1: 4 CORPORATE DRIVE
CITY: ANDOVER
STATE: MA
ZIP: 01810
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-01
0
0001671818
Oncorus, Inc.
ONCR
0001835251
Harbin Stephen
C/O ONCORUS, INC.
4 CORPORATE DRIVE
ANDOVER
MA
01810
0
1
0
0
COO and Chief of Staff
Stock Option (right to buy)
0.67
2022-11-01
4
A
0
150000
0.00
A
2032-11-01
Common Stock
150000
150000
D
The option shall vest as to 50% of the underlying shares on March 31, 2023, and as to the remaining 50% of the underlying shares on December 31, 2023, subject to the Reporting Person continuing to provide service through each such date.
/s/ Brian J. Shea, Attorney-in-Fact
2022-11-02